IL-6 activates tumor cells to induce the expression of STAT3 target genes, which in turn encode proteins that promote tumor growth (such as cyclin D1) and/or survival (such as BCL-2-like protein 1 (BCL-xL) [74]. This evidence concerns the gene BCL2L1 and neoplasm.